Figure 2
Figure 2. Mice lacking p100 have markedly increased numbers of MZ B cells. (A) Splenocytes from wild-type, p100−/−, and nfkb2−/− mice were stained for CD23 and CD21 and analyzed by flow cytometry (lymphocyte gate). Percentages indicate CD23−CD21+ MZ B cells. (B) CD23− (top row) and CD23+ (bottom row) splenocyte subpopulations from wild-type, p100−/−, and nfkb2−/− mice were analyzed for CD21 and IgM expression. Percentages of newly formed T1 B cells (CD23−CD21−IgMhi), T2 B cells (CD23+CD21+IgMhi), MZ B cells (CD23−CD21hiIgMhi), and FO B cells (CD23+CD21intIgMlo) are shown (black regions). Among the T2 B-cell subpopulation, percentages of presumed MZ precursor B cells (MZPB; CD23+CD21hiIgMhi) are indicated (red regions). Representative data from 3 to 4 experiments are shown. (C) Absolute numbers of B-cell subpopulations per 106 splenocytes from wild-type, p100−/−, and nfkb2−/− mice are shown. Error bars indicate standard deviation (SD) from at least 5 mice per genotype. (D) MZ B cells from p100−/− mice show better survival than wild-type controls. Splenocytes were cultured for 48 hours in media or stimulated with LPS or anti-CD40 mAb. Percentages of Annexin-V+ apoptotic cells in MZ and FO B-cell subpopulations are shown. Error bars indicate SD from 3 experiments. Significant differences are indicated (Student t test, *P < .05; **P < .01; ***P < .002). (E) Spleens from p100−/− mice exhibit an enlarged MZ B-cell population adjacent to MOMA-1+ macrophages. Spleen sections from age-matched wild-type and p100−/− mice were stained with anti-IgM for B cells (Vector Blue) and MOMA-1 for MMMs (DAB brown). Objective: × 40. Images were acquired through an AX70 Olympus microscope (Olympus, Hamburg, Germany) with a 40×/0.75 objective by an Olympus DP70 digital camera running analySISB Soft Imaging System software (Olympus) and processed with Adobe Photoshop 8.0 software (Adobe, San Jose, CA).

Mice lacking p100 have markedly increased numbers of MZ B cells. (A) Splenocytes from wild-type, p100−/−, and nfkb2−/− mice were stained for CD23 and CD21 and analyzed by flow cytometry (lymphocyte gate). Percentages indicate CD23CD21+ MZ B cells. (B) CD23 (top row) and CD23+ (bottom row) splenocyte subpopulations from wild-type, p100−/−, and nfkb2−/− mice were analyzed for CD21 and IgM expression. Percentages of newly formed T1 B cells (CD23CD21IgMhi), T2 B cells (CD23+CD21+IgMhi), MZ B cells (CD23CD21hiIgMhi), and FO B cells (CD23+CD21intIgMlo) are shown (black regions). Among the T2 B-cell subpopulation, percentages of presumed MZ precursor B cells (MZPB; CD23+CD21hiIgMhi) are indicated (red regions). Representative data from 3 to 4 experiments are shown. (C) Absolute numbers of B-cell subpopulations per 106 splenocytes from wild-type, p100−/−, and nfkb2−/− mice are shown. Error bars indicate standard deviation (SD) from at least 5 mice per genotype. (D) MZ B cells from p100−/− mice show better survival than wild-type controls. Splenocytes were cultured for 48 hours in media or stimulated with LPS or anti-CD40 mAb. Percentages of Annexin-V+ apoptotic cells in MZ and FO B-cell subpopulations are shown. Error bars indicate SD from 3 experiments. Significant differences are indicated (Student t test, *P < .05; **P < .01; ***P < .002). (E) Spleens from p100−/− mice exhibit an enlarged MZ B-cell population adjacent to MOMA-1+ macrophages. Spleen sections from age-matched wild-type and p100−/− mice were stained with anti-IgM for B cells (Vector Blue) and MOMA-1 for MMMs (DAB brown). Objective: × 40. Images were acquired through an AX70 Olympus microscope (Olympus, Hamburg, Germany) with a 40×/0.75 objective by an Olympus DP70 digital camera running analySISB Soft Imaging System software (Olympus) and processed with Adobe Photoshop 8.0 software (Adobe, San Jose, CA).

Close Modal

or Create an Account

Close Modal
Close Modal